Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2016, Article ID 5459029, 5 pages
http://dx.doi.org/10.1155/2016/5459029
Case Report

Early Diagnosis and Hematopoietic Stem Cell Transplantation for IL10R Deficiency Leading to Very Early-Onset Inflammatory Bowel Disease Are Essential in Familial Cases

1Faculty of Medicine, Department of Pediatric Immunology, Ege University, Izmir, Turkey
2Department of Pediatric Allergy and Immunology Department, Dr. Behcet Uz Children Training and Research Hospital, Izmir, Turkey
3Research Center for Molecular Medicine of the Austrian Academy, Vienna, Austria

Received 25 May 2016; Accepted 11 August 2016

Academic Editor: Juan-Manuel Anaya

Copyright © 2016 Neslihan Edeer Karaca et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Agarwal and L. Mayer, “Gastrointestinal manifestations in primary immune disorders,” Inflammatory Bowel Diseases, vol. 16, no. 4, pp. 703–711, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Loddo and C. Romano, “Inflammatory bowel disease: genetics, epigenetics, and pathogenesis,” Frontiers in Immunology, vol. 6, article 551, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. H. H. Uhlig, T. Schwerd, S. Koletzko et al., “The diagnostic approach to monogenic very early onset inflammatory bowel disease,” Gastroenterology, vol. 147, no. 5, pp. 990–1007, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Bousfiha, L. Jeddane, W. Al-Herz et al., “The 2015 IUIS phenotypic classification for primary immunodeficiencies,” Journal of Clinical Immunology, vol. 35, no. 8, pp. 727–738, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. E.-O. Glocker, N. Frede, M. Perro et al., “Infant colitis—it's in the genes,” The Lancet, vol. 376, no. 9748, p. 1272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. E.-O. Glocker, D. Kotlarz, K. Boztug et al., “Inflammatory bowel disease and mutations affecting the interleukin-10 receptor,” The New England Journal of Medicine, vol. 361, no. 21, pp. 2033–2045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Kühn, J. Löhler, D. Rennick, K. Rajewsky, and W. Müller, “Interleukin-10-deficient mice develop chronic enterocolitis,” Cell, vol. 75, no. 2, pp. 263–274, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. K. W. Moore, R. de Waal Malefyt, R. L. Coffman, and A. O'Garra, “Interleukin-10 and the interleukin-10 receptor,” Annual Review of Immunology, vol. 19, pp. 683–765, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Commins, J. W. Steinke, and L. Borish, “The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29,” The Journal of Allergy and Clinical Immunology, vol. 121, no. 5, pp. 1108–1111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E.-O. Glocker, D. Kotlarz, C. Klein, N. Shah, and B. Grimbacher, “IL-10 and IL-10 receptor defects in humans,” Annals of the New York Academy of Sciences, vol. 1246, no. 1, pp. 102–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. H. Lee, P. Hsu, B. Nanan et al., “Novel de novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel disease,” Journal of Crohn's and Colitis, vol. 8, no. 11, pp. 1551–1556, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Begue, J. Verdier, F. Rieux-Laucat et al., “Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease,” American Journal of Gastroenterology, vol. 106, no. 8, pp. 1544–1555, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Kotlarz, R. Beier, D. Murugan et al., “Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy,” Gastroenterology, vol. 143, no. 2, pp. 347–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. D. S. Shouval, C. L. Ebens, R. Murchie et al., “Large B-cell lymphoma in an adolescent patient with IL-10 receptor deficiency and history of infantile inflammatory bowel disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 63, no. 1, pp. 15–17, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. K. R. Engelhardt, N. Shah, I. Faizura-Yeop et al., “Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation,” Journal of Allergy and Clinical Immunology, vol. 131, no. 3, pp. 825–830, 2013. View at Publisher · View at Google Scholar
  16. B. Neven, E. Mamessier, J. Bruneau et al., “A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency,” Blood, vol. 122, no. 23, pp. 3713–3722, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Murugan, M. H. Albert, J. Langemeier et al., “Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation,” Journal of Clinical Immunology, vol. 34, no. 3, pp. 331–339, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Beier, D. Kotlarz, K. Boztug et al., “Successful allogeneic hematopoietic stem cell transplantation for severe inflammatory bowel disease-IL10 receptor deficiency may serve as a novel therapeutic paradigm,” Blood, vol. 116, article 2379, 2010. View at Google Scholar